ClinicalTrials.gg
Sign In

Gracell Biotechnologies (Shanghai) Co., Ltd. clinical trials

Acquired by AstraZeneca, Feb 22, 2024 · source ↗

The registry lists 3 studies whose lead sponsor is Gracell Biotechnologies (Shanghai) Co., Ltd.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 6, 2026.

Before and after it joined AstraZeneca

First submitted before Gracell Biotechnologies (Shanghai) Co., Ltd. became part of AstraZeneca
1
First submitted after Gracell Biotechnologies (Shanghai) Co., Ltd. became part of AstraZeneca
2
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Gracell Biotechnologies (Shanghai) Co., Ltd.’s studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Gracell Biotechnologies (Shanghai) Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 1F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

All 3 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now267%
  • Under way, not recruiting133%

Phase

  • Phase 13
  • Phase 22

Where

  • China3

Over the years

  1. 123
  2. 24
  3. 25
  4. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Gracell Biotechnologies (Shanghai) Co., Ltd.3 studies

Something wrong with this grouping? Tell us on the AstraZeneca page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All AstraZeneca studies →